ETRADE Capital Management LLC boosted its stake in AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) by 27.6% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,591 shares of the company’s stock after acquiring an additional 777 shares during the period. ETRADE Capital Management LLC’s holdings in AmerisourceBergen were worth $297,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of ABC. Janus Henderson Group PLC boosted its holdings in AmerisourceBergen by 660.8% in the 2nd quarter. Janus Henderson Group PLC now owns 2,574,746 shares of the company’s stock valued at $243,392,000 after purchasing an additional 2,236,319 shares in the last quarter. Wells Fargo & Company MN boosted its holdings in AmerisourceBergen by 42.9% in the 2nd quarter. Wells Fargo & Company MN now owns 3,344,441 shares of the company’s stock valued at $316,149,000 after purchasing an additional 1,003,327 shares in the last quarter. Franklin Resources Inc. boosted its holdings in AmerisourceBergen by 23.1% in the 2nd quarter. Franklin Resources Inc. now owns 3,902,289 shares of the company’s stock valued at $368,884,000 after purchasing an additional 731,466 shares in the last quarter. Parametric Portfolio Associates LLC boosted its holdings in AmerisourceBergen by 123.4% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 1,157,612 shares of the company’s stock valued at $109,429,000 after purchasing an additional 639,515 shares in the last quarter. Finally, FMR LLC boosted its holdings in AmerisourceBergen by 68.9% in the 2nd quarter. FMR LLC now owns 1,094,072 shares of the company’s stock valued at $103,422,000 after purchasing an additional 446,308 shares in the last quarter. Hedge funds and other institutional investors own 67.83% of the company’s stock.

Shares of AmerisourceBergen Corporation (NYSE ABC) opened at $87.42 on Tuesday. The company has a market capitalization of $18,526.06, a P/E ratio of 14.42, a PEG ratio of 1.47 and a beta of 1.00. The company has a debt-to-equity ratio of 1.83, a quick ratio of 0.48 and a current ratio of 0.91. AmerisourceBergen Corporation has a 52 week low of $71.90 and a 52 week high of $97.85.

AmerisourceBergen (NYSE:ABC) last issued its quarterly earnings data on Thursday, November 2nd. The company reported $1.33 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.32 by $0.01. AmerisourceBergen had a return on equity of 56.29% and a net margin of 0.27%. The firm had revenue of $39.12 billion during the quarter, compared to the consensus estimate of $40.10 billion. During the same period in the previous year, the firm posted $1.30 EPS. The company’s quarterly revenue was up 4.2% compared to the same quarter last year. research analysts expect that AmerisourceBergen Corporation will post 6.06 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 4th. Investors of record on Monday, November 20th were given a dividend of $0.38 per share. This is an increase from AmerisourceBergen’s previous quarterly dividend of $0.37. This represents a $1.52 annualized dividend and a dividend yield of 1.74%. The ex-dividend date of this dividend was Friday, November 17th. AmerisourceBergen’s payout ratio is currently 82.16%.

ABC has been the topic of several research analyst reports. Deutsche Bank initiated coverage on AmerisourceBergen in a research note on Monday. They set a “buy” rating and a $97.00 price target on the stock. Robert W. Baird set a $99.00 price target on AmerisourceBergen and gave the stock a “buy” rating in a research note on Friday. Needham & Company LLC boosted their price target on AmerisourceBergen from $86.00 to $88.00 and gave the stock a “buy” rating in a research note on Wednesday, November 22nd. ValuEngine raised AmerisourceBergen from a “hold” rating to a “buy” rating in a research note on Tuesday, October 31st. Finally, Jefferies Group set a $85.00 price target on AmerisourceBergen and gave the stock a “hold” rating in a research note on Sunday, October 29th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company’s stock. AmerisourceBergen currently has an average rating of “Buy” and a consensus price target of $91.95.

In related news, insider Dale Danilewitz sold 2,012 shares of AmerisourceBergen stock in a transaction that occurred on Thursday, October 5th. The stock was sold at an average price of $85.00, for a total transaction of $171,020.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Tim G. Guttman sold 11,600 shares of AmerisourceBergen stock in a transaction that occurred on Wednesday, September 20th. The stock was sold at an average price of $79.47, for a total value of $921,852.00. The disclosure for this sale can be found here. Insiders have sold a total of 153,807 shares of company stock valued at $12,316,290 over the last 90 days. Insiders own 27.40% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “ETRADE Capital Management LLC Buys 777 Shares of AmerisourceBergen Corporation (Holding Co) (ABC)” was reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this story on another website, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this story can be viewed at https://theolympiareport.com/2017/12/05/etrade-capital-management-llc-buys-777-shares-of-amerisourcebergen-corporation-holding-co-abc.html.

AmerisourceBergen Profile

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.

Institutional Ownership by Quarter for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Corporation (Holding Co) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen Corporation (Holding Co) and related companies with Analyst Ratings Network's FREE daily email newsletter.